Inhibition of Human Breast and Prostate Cancer Cell Proliferation
http://endo.endojournals.org/cgi/con…ract/141/1/118
Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer
http://cancerres.aacrjournals.org/cg…/65/5/1635.pdf Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2930808/?toolubmed
The endocannabinoid system and cancer: therapeutic implication (full – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3280884/
Phytocannabinoids for use in the treatment of cancer - Patent GB2478595 (A) ―2011-09-14 (full – 2011) http/worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT&ND=&date=20110914&DB=&locale=en_EP
The endocannabinoid system in prostate cancer. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21912423
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21995886
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/20838378
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?toolubmed
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells (full – 2012) http/endo.endojournals.org/content/153/1/29.full
Towards the use of non-psychoactive cannabinoids for prostate cancer. (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02121.x/pdf
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23262399
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23069587
Is Marijuana the Cancer Cure We’ve Waited For? (news – 2012) http/www.empowher.com/cancer/content/marijuana-cancer-cure-we-ve-waited
Tommy Chong Fighting Prostate Cancer With Cannabis Oil (news – 2012) http/www.cannabisculture.com/content/2012/06/10/Tommy-Chong-Fighting-Prostate-Cancer-Cannabis-Oil
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: proapoptotic effects and underlying mechanisms. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0065798
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full – 2013) http/www.hindawi.com/journals/ije/2013/259676/
US Patent Application 20130059018 - PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full – 2013) http/www.google.com/patents/US20130059018
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity. (abst – 2013) http/www.sciencedirect.com/science/article/pii/S0223523413006247
Tommy Chong Is "Cancer Free;" Claims Marijuana Cures Cancer (news – 2013) http/www.medicaldaily.com/articles/15600/20130516/tommy-chong-cancer-free-prostate-cancermarijuana.htm
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4109781/
Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3900727/
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http/www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path[]=2233
Honokiol inhibits androgen receptor activity in prostate cancer cells (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24338950
Proapoptotic effect of endocannabinoids in prostate cancer cells (link to PDF– 2015) http://www.spandidos-publications.co...2/or.2015.3746
http://endo.endojournals.org/cgi/con…ract/141/1/118
Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer
http://cancerres.aacrjournals.org/cg…/65/5/1635.pdf Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. (full – 2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2930808/?toolubmed
The endocannabinoid system and cancer: therapeutic implication (full – 2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3280884/
Phytocannabinoids for use in the treatment of cancer - Patent GB2478595 (A) ―2011-09-14 (full – 2011) http/worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT&ND=&date=20110914&DB=&locale=en_EP
The endocannabinoid system in prostate cancer. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21912423
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21995886
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/20838378
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3339795/?toolubmed
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells (full – 2012) http/endo.endojournals.org/content/153/1/29.full
Towards the use of non-psychoactive cannabinoids for prostate cancer. (full – 2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02121.x/pdf
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23262399
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/23069587
Is Marijuana the Cancer Cure We’ve Waited For? (news – 2012) http/www.empowher.com/cancer/content/marijuana-cancer-cure-we-ve-waited
Tommy Chong Fighting Prostate Cancer With Cannabis Oil (news – 2012) http/www.cannabisculture.com/content/2012/06/10/Tommy-Chong-Fighting-Prostate-Cancer-Cannabis-Oil
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: proapoptotic effects and underlying mechanisms. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02027.x/full
Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0065798
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full – 2013) http/www.hindawi.com/journals/ije/2013/259676/
US Patent Application 20130059018 - PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full – 2013) http/www.google.com/patents/US20130059018
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity. (abst – 2013) http/www.sciencedirect.com/science/article/pii/S0223523413006247
Tommy Chong Is "Cancer Free;" Claims Marijuana Cures Cancer (news – 2013) http/www.medicaldaily.com/articles/15600/20130516/tommy-chong-cancer-free-prostate-cancermarijuana.htm
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4109781/
Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3900727/
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF- 2014) http/www.impactjournals.com/oncotarget/index.php?journalncotarget&page=article&op=view&path[]=2233
Honokiol inhibits androgen receptor activity in prostate cancer cells (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24338950
Proapoptotic effect of endocannabinoids in prostate cancer cells (link to PDF– 2015) http://www.spandidos-publications.co...2/or.2015.3746